Hypersecretion of insulin after the administration of L-leucine to obese children.
D000015:Abnormalities, Multiple / Q000150:complications; D000284:Administration, Oral; D000293:Adolescent; D001786:Blood Glucose / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007006:Hypogonadism / Q000150:complications; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D008607:Intellectual Disability / Q000150:complications; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D007849:Laurence-Moon Syndrome / Q000150:complications; D007930:Leucine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D009765:Obesity / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D013268:Stimulation, Chemical
D001786:Blood Glucose; D007328:Insulin; D007930:Leucine